Equities

Medicamen Biotech Ltd

MEDICAMEQ:NSI

Medicamen Biotech Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)462.95
  • Today's Change11.95 / 2.65%
  • Shares traded51.91k
  • 1 Year change-30.90%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 11:01 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue1,7931,4091,154
OPERATING EXPENSES
Cost of revenue total1,095860656
Selling, general and admin. expenses, total323218176
Depreciation/amortization716458
Unusual expense(income)--0--
Other operating expenses, total1509186
Total operating expense1,6401,232976
Operating income153176179
Other, net(8.79)(0.52)(0.04)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes131170181
Provision for income taxes362332
Net income after taxes95147149
Minority interest141.16--
Net income before extra. Items109148149
Total extraordinary items------
Net income109148149
Inc.avail. to common excl. extra. Items109148149
Inc.avail. to common incl. extra. Items109148149
EPS RECONCILIATION
Basic/primary weighted average shares131212
Basic/primary eps excl. extra items8.631212
Basic/primary eps incl. extra items8.631212
Dilution adjustment------
Diluted weighted average shares131212
Diluted eps excl. extra items8.631212
Diluted eps incl. extra items8.631212
COMMON STOCK DIVIDENDS
DPS - common stock primary issue1.001.001.00
Gross dividend - common stock131312
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental342714
SUPPLEMENTAL INCOME
Depreciation, supplemental696357
Total special items0.730.070.00
NORMALISED INCOME
Normalized income before taxes131171181
Effect of special items on income taxes0.200.010.00
Income tax excluding impact of special items362332
Normalized income after tax95147149
Normalized income avail. to common110148149
Basic normalized EPS8.681212
Diluted normalized EPS8.681212
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.